Business Context and Reporting Period
Company: NeOnc Technologies Holdings, Inc. (NTHI)
Filing Type: Form 8-K (Current Report)
Date of Report: June 6, 2025
Reporting Period: Single event date (June 6, 2025)
Business Context: The registrant is an emerging growth company incorporated in Delaware, with principal executive offices in Calabasas, CA. The filing serves as a Regulation FD disclosure regarding a material corporate event.
Key Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material change disclosed in this report is a personnel appointment:
- Appointment: Dr. Neman has been appointed as the Chief Clinical Officer.
- Disclosure Method: The details were communicated via a press release issued on June 6, 2025, furnished as Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release regarding the new leadership appointment but does not include specific forward-looking guidance, financial outlook, or detailed management commentary within the text of the 8-K itself.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in this filing beyond the standard legal disclaimers regarding the non-filing status of the press release for Section 18 liability purposes.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for details on Dr. Neman's background and the strategic rationale for the appointment.
- Confirm the effective date of Dr. Neman's role as Chief Clinical Officer.
- Review subsequent filings (e.g., 10-Q or 10-K) for any financial impact or compensation details related to this executive appointment.